Brain functional alterations in Type 2 Diabetes – A systematic review of fMRI studies

Macpherson, Helen; Formica, Melissa; Harris, Elizabeth; Daly, Robin M.

doi:10.1016/j.yfrne.2017.07.001

Cited by 85 publications

(76 citation statements)

References 77 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Furthermore, the loss of brain volume has been described in patients with diabetes, particularly in regions of the hippocampus, thalamus, and cerebellar area 42 . Meta-analysis identified reduced resting-state brain activity in all brain regions in individuals with type 2 diabetes 43 be one of the main complications of diabetes, according to the current recommendations for good practice in the care of individuals with diabetes, it has become important to perform cognitive screening or cognitive assessment of these individuals 13,44,45 .…”

Section: Discussionmentioning

confidence: 99%

Association between diabetes and cognitive function at baseline in the Brazilian Longitudinal Study of Adult Health (ELSA- Brasil)

Teixeira

Passos

Barreto

et al. 2020

Sci Rep

View full text Add to dashboard Cite

Diabetes has been associated with cognitive changes and an increased risk of vascular dementia andAlzheimer's disease, but it is unclear whether there are associations between diabetes and early alterations in cognitive performance. The present study consisted of a cross-section analysis of 14,444 participants aged 35-74 years and from a developing country at baseline in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil); these participants were recruited between 2008 and 2010. We investigated whether there was an association between diabetes and early changes in the cognitive performance of this Brazilian population. To assess cognitive domains, we used the word-list learning, word-list delayed recall and word recognition tests along. Phonemic verbal fluency tests included semantic phonemic test (animals) and a phonemic test (words beginning with the letter f). executive functions associated with attention, concentration and psychomotor speed were evaluated using the Trail Making Test B. The exposure variable in the study was defined as diabetes. Multiple linear regression was used to estimate the association between diabetes and cognitive performance. the results were adjusted for age, sex, education, hypertension, coronary disease, depression, physical activity, smoking, alcohol consumption, and the cholesterol/HDL-C ratio. We found a significant association between diabetes and decreased memory, language and executive function (attention, concentration and psychomotor speed) performance in this population from a country with a distinct epidemiological profile, even after adjusting for the main intervening variables.The world population is ageing, and the incidence of neurodegenerative diseases associated with age is increasing. Diabetes mellitus (diabetes) has been associated with cognitive changes and an increased risk of vascular dementia 1 and Alzheimer's disease 2 . The number of people diagnosed with diabetes worldwide is approximately 422 million individuals 3 . Cognitive dysfunction in individuals with diabetes can result from interactions between inherent metabolic abnormalities, such as hyperglycaemia, hyperinsulinaemia, and micro-and macrovascular complications, in addition to hypertension, dyslipidaemia, depression and obesity 4-7 . The precise mechanisms involved in degenerative diseases in patients with diabetes are unknown and not fully understood; thus, they are considered quite complex and dynamic 8 .Some studies show a worse performance in cognitive tests among patients with diabetes than among individuals without diabetes, with deficits in several domains, especially executive function, memory, psychomotor speed and attention 9,10 . A systematic review that included case-control and population-based studies showed that the risk of overall cognitive dysfunction was increased in people with diabetes in five of seven cohorts. In addition, the association of decreased cognitive performance in one or more domains in was reported in 13 of the 20 cross-sectional studies and in five of t...

show abstract

Section: Discussionmentioning

confidence: 99%

Association between diabetes and cognitive function at baseline in the Brazilian Longitudinal Study of Adult Health (ELSA- Brasil)

Teixeira

Passos

Barreto

et al. 2020

Sci Rep

View full text Add to dashboard Cite

show abstract

“…Brain imaging studies have documented reduced gray matter volumes and white matter integrity in multiple brain regions, and reduced functional connectivity between brain regions in obese individuals, particularly those with abdominal obesity and insulin resistance (Debette et al, 2014; Janowitz et al, 2015; Kullmann et al, 2015). Generally similar abnormalities in brain structure and neuronal network connectivity occur in individuals with type 2 diabetes (Macpherson et al, 2017). Even among individuals who are not obese, higher body mass index is associated with perturbed resting state connectivity in the DMN and sensory-motor networks (Beyer et al, 2017; Doucet et al, 2018).…”

Section: Metabolic Factors Can Accelerate or Decelerate Brain Agingmentioning

confidence: 99%

Hallmarks of Brain Aging: Adaptive and Pathological Modification by Metabolic States

2018

View full text Add to dashboard Cite

During aging, the cellular milieu of the brain exhibits tell-tale signs of compromised bioenergetics, impaired adaptive neuroplasticity and resilience, aberrant neuronal network activity, dysregulation of neuronal Ca2+ homeostasis, the accrual of oxidatively modified molecules and organelles, and inflammation. These alterations render the aging brain vulnerable to Alzheimer’s and Parkinson’s diseases and stroke. Emerging findings are revealing mechanisms by which sedentary overindulgent lifestyles accelerate brain aging, whereas lifestyles that include intermittent bioenergetic challenges (exercise, fasting, and intellectual challenges) foster healthy brain aging. Here we provide an overview of the cellular and molecular biology of brain aging, how those processes interface with disease-specific neurodegenerative pathways, and how metabolic states influence brain health.

show abstract

“…The frequency has been intensifying the most in middle and low income countries. Throughout the world, type 2 diabetes mellitus (T2DM) is a rapidly developing human health issue (Macpherson, Formica, Harris & Daly, ; B. B. Zhang, Zhou, & Li, ).…”

Section: Introductionmentioning

confidence: 99%

Targeting AMPK signaling pathway by natural products for treatment of diabetes mellitus and its complications

Joshi

Singh

Haratipour

et al. 2019

Journal Cellular Physiology

118

View full text Add to dashboard Cite

Diabetes affects a large population of the world. Lifestyle, obesity, dietary habits, and genetic factors contribute to this metabolic disease. A target pathway to control diabetes is the 5′‐adenosine monophosphate‐activated protein kinase (AMPK) signaling pathway. AMPK is a heterotrimeric protein with α, β, and γ subunits. In several studies, AMPK activation enhanced glucose uptake into cells and inhibited intracellular glucose production. Impairment of AMPK activity is present in diabetes, according to some studies. Drugs used in the treatment of diabetes, such as metformin, are also known to act through regulation of AMPK. Thus, drugs that activate and regulate AMPK are potential candidates for the treatment of diabetes. In addition, many patients encounter important adverse effects, like hypoglycemia, while using allopathic drugs. As a result, the investigation of plant‐derived natural drugs that lack adverse side effects and treat diabetes is necessary. Natural products like berberine, quercetin, resveratrol, and so forth have shown significant potential in regulating and activating the AMPK pathway which can lead to manage diabetes mellitus and its complications.

show abstract

Brain functional alterations in Type 2 Diabetes – A systematic review of fMRI studies

Cited by 85 publications

References 77 publications

Association between diabetes and cognitive function at baseline in the Brazilian Longitudinal Study of Adult Health (ELSA- Brasil)

Association between diabetes and cognitive function at baseline in the Brazilian Longitudinal Study of Adult Health (ELSA- Brasil)

Hallmarks of Brain Aging: Adaptive and Pathological Modification by Metabolic States

Targeting AMPK signaling pathway by natural products for treatment of diabetes mellitus and its complications

Contact Info

Product

Resources

About